AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Di Marco, R Puglisi, G Papaccio, G Nicoletti, A Patti, F Reggio, A Bendtzen, K Nicoletti, F
Citation: R. Di Marco et al., Sodium fusidate (fusidin) ameliorates the course of monophasic experimental allergic encephalomyelitis in the Lewis rat, MULT SCLER, 7(2), 2001, pp. 101-104

Authors: Rocca, WA Savettieri, G Anderson, DW Meneghini, F Grigoletto, F Morgante, L Reggio, A Salemi, G Patti, F Di Perri, R
Citation: Wa. Rocca et al., Door-to-door prevalence survey of epilepsy in three Sicilian municipalities, NEUROEPIDEM, 20(4), 2001, pp. 237-241

Authors: Nicoletti, F Di Marco, R Mangano, K Patti, F Reggio, E Nicoletti, A Bendtzen, K Reggio, A
Citation: F. Nicoletti et al., Increased serum levels of interleukin-18 in patients with multiple sclerosis, NEUROLOGY, 57(2), 2001, pp. 342-344

Authors: Nicoletti, A Lo Bartolo, ML Lo Fermo, S Cocuzza, V Panetta, MR Marletta, C Ciancio, MR Cataldi, ML Patti, F Reggio, A
Citation: A. Nicoletti et al., Prevalence and incidence of multiple sclerosis in Catania, Sicily, NEUROLOGY, 56(1), 2001, pp. 62-66

Authors: Patti, F Cataldi, ML Nicoletti, F Reggio, E Nicoletti, A Reggio, A
Citation: F. Patti et al., Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis, J NE NE PSY, 71(3), 2001, pp. 404-407

Authors: Nicoletti, F Di Marco, R Patti, F Zaccone, P L'Episcopo, MR Reggio, E Xiang, M Nicoletti, A Reggio, A
Citation: F. Nicoletti et al., Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)beta 1b transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1 beta, IL-2, IL-4 and tumour necrosis factor-alpha, CYTOKINE, 12(6), 2000, pp. 682-687

Authors: Nicoletti, F Di Marco, R Patti, F Nicoletti, A Leonardi, C Reggio, E Meroni, P Reggio, A
Citation: F. Nicoletti et al., The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta 1b treatment, that neither modifies its ex vivo secretion from peripheral blood mononuclear cells, AUTOIMMUN, 32(4), 2000, pp. 265-270

Authors: Morgante, L Salemi, G Meneghini, F Di Rosa, AE Epifanio, A Grigoletto, F Ragonese, P Patti, F Reggio, A Di Perri, R Savettieri, G
Citation: L. Morgante et al., Parkinson disease survival - A population-based study, ARCH NEUROL, 57(4), 2000, pp. 507-512

Authors: Nicoletti, F Patti, F Nicoletti, A L'Episcopo, MR DiMarco, R Bendtzen, K Reggio, A
Citation: F. Nicoletti et al., Sodium fusidate in steroid resistant relapses of multiple sclerosis, MULT SCLER, 5(6), 1999, pp. 377-377

Authors: Patti, F L'Episcopo, MR Cataldi, ML Reggio, A
Citation: F. Patti et al., Natural interferon-beta treatment of relapsing-remitting and secondary-progressive multiple sclerosis patients. A two-year study, ACT NEUR SC, 100(5), 1999, pp. 283-289

Authors: Rocca, WA Reggio, A Savettieri, G Salemi, G Patti, F Meneghini, F Grigoletto, F Morgante, L Di Perri, R
Citation: Wa. Rocca et al., Stroke incidence and survival in three Sicilian municipalities, ITAL J NEUR, 19(6), 1998, pp. 351-356
Risultati: 1-11 |